N-Carbamyl-L-Glutamic acid - CAS 1188-38-1
Catalog number: 1188-38-1
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6H10N2O5
Molecular Weight:
190.15
COA:
Inquire
Targets:
Others
Description:
N-Carbamyl-L-Glutamic acid is an orphan drug which is applicated for the treatment of hyperammonaemia in patients that has N-acetylglutamate synthase deficiency. In Jul 2014, Carglumic acid received Orphan Drug status for Organic acidaemias in USA. In Sep 2015, Carglumic acid registered for Hyperammonaemia in Canada .
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
White to Off-White Solid
Synonyms:
Carbaglu; Carbamino-L-glutamic Acid; Carbamylglutamic Acid; Carglumic Acid; N-Carbamoyl-L-glutamic Acid; N-Carbamoyl-S-glutamic Acid; N-Carbamyl-L-glutamic Acid; OE 312; Ureidoglutaric Acid; N-(Aminocarbonyl)-L-glutamic Acid;
Solubility:
DMSO (Slightly), Methanol (Slightly)
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
the treatment of acute hyperammonemia
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Boiling Point:
438.1ºC at 760 mmHg
Melting Point:
150-154°C
Density:
1.499g/cm3
InChIKey:
LCQLHJZYVOQKHU-VKHMYHEASA-N
InChI:
InChI=1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1
Canonical SMILES:
C(CC(=O)O)C(C(=O)O)NC(=O)N
Current Developer:
Originator:Orphan Europe
1.[Determination of N-carbamyl-L-glutamic acid in feedstuff by high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Tang S, Wang Y, Wen P, Xin Z. Se Pu. 2014 Feb;32(2):184-8.
A method was developed for the determination of N-carbamyl-L-glutamic acid (NCG) in feedstuff by high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). The feedstuff samples were extracted with methanol, cleaned-up by a ProElut mixed-mode of strong anion exchange inverse column (PXA). Then the samples were separated with HPLC and detected with MS/MS in multiple reaction monitoring (MRM) mode via positive electrospray ionization (ESI+). The fragment ions of m/z 148.0 and m/z 84.0 were used for qualitative analysis, and m/z 130.0 was selected for quantitative analysis. The limit of detection for NCG was 24 microg/kg (S/N > 3), and the limit of quantification was 80 microg/kg (S/N > 10). The standard calibration curve was linear over the range of 20-1,000 microg/L, and the correlation coefficient was 0. 999 9. The recoveries of NCG in feedstuff were 104.0%, 103.5%, 95.3%, at the three spiked levels of 80, 200, 500 mg/kg with the relative standard deviations (RSDs) of 7.
2.A liver-specific defect of Acyl-CoA degradation produces hyperammonemia, hypoglycemia and a distinct hepatic Acyl-CoA pattern.
Gauthier N1, Wu JW, Wang SP, Allard P, Mamer OA, Sweetman L, Moser AB, Kratz L, Alvarez F, Robitaille Y, Lépine F, Mitchell GA. PLoS One. 2013 Jul 5;8(7):e60581. doi: 10.1371/journal.pone.0060581. Print 2013.
Most conditions detected by expanded newborn screening result from deficiency of one of the enzymes that degrade acyl-coenzyme A (CoA) esters in mitochondria. The role of acyl-CoAs in the pathophysiology of these disorders is poorly understood, in part because CoA esters are intracellular and samples are not generally available from human patients. We created a mouse model of one such condition, deficiency of 3-hydroxy-3-methylglutaryl-CoA lyase (HL), in liver (HLLKO mice). HL catalyses a reaction of ketone body synthesis and of leucine degradation. Chronic HL deficiency and acute crises each produced distinct abnormal liver acyl-CoA patterns, which would not be predictable from levels of urine organic acids and plasma acylcarnitines. In HLLKO hepatocytes, ketogenesis was undetectable. Carboxylation of [2-(14)C] pyruvate diminished following incubation of HLLKO hepatocytes with the leucine metabolite 2-ketoisocaproate (KIC). HLLKO mice also had suppression of the normal hyperglycemic response to a systemic pyruvate load, a measure of gluconeogenesis.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 109229-57-4 Englitazone sodium

Englitazone sodium
(CAS: 109229-57-4)

Englitazone sodium is a novel blocker of NSCa and KATP channels. It is an antidiabetic agent.

CAS 225521-80-2 BMS-243117

BMS-243117
(CAS: 225521-80-2)

BMS-243117 is a potent and selective Lck inhibitor with good cellular activity against T-cell proliferation. BMS-24311 has potential to treat diseases such as r...

CAS 1187-84-4 S-Methyl-L-cysteine

S-Methyl-L-cysteine
(CAS: 1187-84-4)

S-Methyl-L-cysteine, a theurapeutic for neurodegenerative diseases, is a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductas...

Netupitant N-Oxide
(CAS: 910808-11-6)

Netupitant N-Oxide is a derivative of Netupitant which is a potent and selective neurokinin-1 receptor (NK1) receptor antagonist. It is achiral and orally activ...

Namitecan
(CAS: 372105-27-6)

Namiteca is a new water-soluble camptothecin analogue as a hydrophilic camptothecin with a promising preclinical profile.

CAS 881970-80-5 iMDK

iMDK
(CAS: 881970-80-5)

iMDK is an inhibitor of midkine (MDK) expression, a growth factor commonly expressed in malignant tumors. iMDK dose-dependently inhibits MDK expression to atten...

Epelsiban
(CAS: 872599-83-2)

Epelsiban is an oxytocin receptor antagonist under the developement of GlaxoSmithKline. It has high affinity for the oxytocin receptor (Ki = 0.13 nM) with >31,0...

CAS 55-06-1 Liothyronine Sodium

Liothyronine Sodium
(CAS: 55-06-1)

Liothyronine Sodium is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis.

CAS 20977-50-8 Carperone

Carperone
(CAS: 20977-50-8)

Carperone, a butyrophenone derivative, is a bio-active chemical.

CI 750
(CAS: 47739-68-4)

CI-750 is a novel antidiarrheal agent.

CAS 141993-70-6 Eldacimibe

Eldacimibe
(CAS: 141993-70-6)

Eldacimibe is a Sterol O-acyltransferase inhibitor originated by Wyeth. No development was reported for Atherosclerosis and Hypercholesterolaemia in USA.

CGP 20376
(CAS: 81059-04-3)

CGP 20376 is a benzothiazole compound and it has antifilarial properties.

CAS 80681-45-4 Prim-o-glucosylcimifugin

Prim-o-glucosylcimifugin
(CAS: 80681-45-4)

Prim-O-glucosylcimifugin is a natural product extracted from the root of Saposhnikovia divaricata (Turcz.) Schischk. It can inhibit the proliferation of SMC(smo...

CAS 60-27-5 Creatinine

Creatinine
(CAS: 60-27-5)

Creatinine is a break-down product of creatine phosphate in muscle, and is usually produced at a fairly constant rate by the body.

CAS 258264-62-9 S 12

S 12
(CAS: 258264-62-9)

S 12 is a survivin inhibitor that alters spindle formation, resulting in mitotic arrest (by disrupting metaphase at the G2/M stage) and apoptosis. It inhibits c...

CAS 33173-53-4 4-Azido-L-phenylalanine

4-Azido-L-phenylalanine
(CAS: 33173-53-4)

4-Azido-L-phenylalanine is an unnatural derivative of L-phenylalanine. It is a nonpolar, essential amino acid that naturally occurs in the human body and is als...

CAS 6892-68-8 Dithioerythritol

Dithioerythritol
(CAS: 6892-68-8)

Dithioerythritol, a sulfur containing sugar derived from the corresponding 4-carbon monosaccharide erythrose, is an epimer of dithiothreitol(DTT).

OTX008
(CAS: 286936-40-1)

OTX008, a calixarene derivative, is a galectin-1 (Gal-1) inhibitor with potential anti-angiogenic and antineoplastic activities. In vitro, OTX008 effects in a p...

GSK-7975A
(CAS: 1253186-56-9)

This active molecular is a calcium release-activated calcium modulator (ORAI1) inhibitor. GSK-7975A inhibited toxin-induced activation of ORAI1 and/or activatio...

CAS 66-97-7 Psoralen

Psoralen
(CAS: 66-97-7)

Psoralen is an active ingredient from Fructus Psoraleae and has anticancer activity.

Chemical Structure

CAS 1188-38-1 N-Carbamyl-L-Glutamic acid

Quick Inquiry

Verification code

Featured Items